New Rochelle, NY, June 26, 2014-Psychostimulant use to treat children and adolescents with attention-deficit/hyperactivity disorder is increasing worldwide, and the evaluation of the cardiovascular safety of stimulant medication used in treatment has been a recent topic of concern.
via New Rochelle Newswire http://ift.tt/1pSqL6S
via New Rochelle Newswire http://ift.tt/1pSqL6S
No comments:
Post a Comment